A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations

References

• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
   PubMed Web of Science ®Google Scholar
• Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4(Suppl 3):5265–72.
   Google Scholar
• Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344:907–16.
   PubMed Web of Science ®Google Scholar
• van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow-up study. Ann Rheum Dis. 1992;51:1029–35.
   Google Scholar
• Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-spe-cific autoantibodies. J Clin Invest. 1998;101:273–81.
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium. Genome-wide asso-ciation study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–78.
   PubMed Web of Science ®Google Scholar
• Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The con-tribution of HLA to rheumatoid arthritis. Clin Genet. 1989;36: 178–82.
   PubMed Web of Science ®Google Scholar
• Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokka-fingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004;75: 330–7.
   Google Scholar
• Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheu-matoid arthritis. Nat Genet. 2003;34:395–402.
   PubMed Web of Science ®Google Scholar
• Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and sys-temic lupus erythematosus. N Engl J Med. 2007;357:977–86.
   PubMed Web of Science ®Google Scholar
• Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med. 2007;13:455–60.
   PubMed Web of Science ®Google Scholar
• Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005;6: 95–108.
   PubMed Web of Science ®Google Scholar
• Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene asso-ciations with rheumatoid arthritis in 4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77:1044–60.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Gomes I, Collins A, Lonjou C, Thomas NS, Wilkinson J, Watson M, et al. Hardy-Weinberg quality control. Ann Hum Genet. 1999;63:535–8.
   PubMed Web of Science ®Google Scholar
• Freidlin B, Zheng G, Li Z, Gastwirth JL. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered. 2002;53:146–52.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
   PubMed Web of Science ®Google Scholar
• Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007;315: 848–53.
   PubMed Web of Science ®Google Scholar
• Oakey RJ, Howard TA, Hogarth PM, Tani K, Seldin MF. Chromosomal mapping of the high affinity Fe gamma receptor gene. Immunogenetics. 1992;35:279–82.
   Google Scholar
• Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-anal-ysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42:508–14.
   PubMed Web of Science ®Google Scholar
• Dijstelbloem HM, Scheepers RH, Oost WW, Stegeman CA, van der Pol WL, Sluiter WJ, et al. Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum. 1999;42:1823–7.
   Google Scholar
• Myhr KM, Raknes G, Nyland H, Vedeler C. Immunoglobulin G Fe-receptor (FegammaR) HA and MB polymorphisms related to disability in MS. Neurology. 1999;52:1771–6.
   PubMed Web of Science ®Google Scholar
• Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome lq in African-American pedigrees. Proc Natl Acad Sci USA. 1998;95:14869–74.
   Google Scholar
• Manger K, Repp R, Jansen M, Geisselbrecht M, Wassmuth R, Westerdaal NA, et al. Fe gamma receptor Ha, Ina, and IIIb polymorphisms in German patients with systemic lupus erythe-matosus: association with clinical symptoms. Ann Rheum Dis. 2002;61:786–92.
   PubMed Web of Science ®Google Scholar
• Diaz de Stahl T, Andren M, Martinsson P, Verbeek JS, Kleinau S. Expression of FegammaRIII is required for development of col-lagen-induced arthritis. Eur J Immunol. 2002;32:2915–22.
   PubMed Web of Science ®Google Scholar
• Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fc gamma receptors. J Exp Med. 2000;191:1611–6.
   Google Scholar
• Magnusson SE, Engstrom M, Jacob U, Ulfgren AK, Kleinau S. High synovial expression of the inhibitory FegammaRllb in rheumatoid arthritis. Arthritis Res Ther. 2007;9:R51.
   Google Scholar
• Marques RB, Thabet MM, White SJ, Houwing-Duistermaat JJ, Bakker AM, Hendriks GJ, et al. Genetic variation of the Fe gamma receptor 3B gene and association with rheumatoid arthritis. PLoS One. 2010;5.
   Google Scholar
• McKinney C, Fanciulli M, Merriman ME, Phipps-Green A, Alizadeh BZ, Koeleman BP, et al. Association of variation in Fe gamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis. 2010;69: 1711–6.
   Google Scholar
• Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet. 2010; 19:3282–94.
   PubMed Web of Science ®Google Scholar
• Van Kuilenburg AB, van Lenthe H, Blom MJ, Mu! EP, Van Gennip AH. Profound variation in dihydropyrimidine dehydro-genase activity in human blood cells: major implications for the detection of partly deficient patients. Br J Cancer. 1999;79:620–6.
   Google Scholar
• Goodman SR, Shiffer KA, Casoria LA, Eyster ME. Identification of the molecular defect in the erythrocyte membrane skeleton of some kindreds with hereditary spherocytosis. Blood. 1982;60: 772–84.
   PubMed Web of Science ®Google Scholar
• Eber SW, Morris SA, Schroter W, Gratzer WB. Interactions of spectrin in hereditary elliptocytes containing truncated spectrin beta-chains. J Clin Invest. 1988;81:523–30.
   PubMed Web of Science ®Google Scholar
• Shrivastav M, Mittal B, Aggarwal A, Misra R. Autoantibodies against cytoskeletal proteins in rheumatoid arthritis. Clin Rheu-matol. 2002;21:505–10.
   PubMedGoogle Scholar